A Special General Meeting of shareholders was held on March 2, 2026. Shareholders approved all five ordinary resolutions submitted for a vote. The resolutions pertain to the exercisability of various warrants and the issuance of underlying American Depositary Shares (ADSs) and ordinary shares. These warrants were issued in connection with a registered direct offering and concurrent private placement (December 17, 2025, and January 20, 2026), a private placement offering (December 23, 2025), and an exchange of notes (December 17, 2025). The approvals cover Series G Warrants, Placement Agent Warrants, Pre-Funded Warrants, and Note Exchange Warrants. In total, the approvals enable the exercisability of warrants to purchase up to an aggregate of 44,028,832 American Depositary Shares (ADSs). Each ADS represents 2,000 ordinary shares, meaning the approvals cover up to 88,057,664,000 ordinary shares. The number of ordinary shares entitled to vote at the meeting was 91,567,009,533.